Dr Agarwal's Hea — 360° view

Dr Agarwal's Hea, a company in the Hospital industry, reported revenue of ₹655 crore and net profit of ₹57 crore for the September 2026 quarter.

Dr Agarwal's Hea (NSE: AGARWALEYE) closed at ₹553.40 on 20 Nov 2026, up 11.8% over the past year. Its market capitalisation is ₹17,545 crore and it trades at 98.0 times earnings.

Share price
₹553.40 (20 Nov 2026)
Market cap
₹17,545 Cr (20 Nov 2026)
P/E
97.95 (20 Nov 2026)
Revenue
₹655 Cr (September 2026 quarter)
Net profit
₹57 Cr (September 2026 quarter)
ROCE
10.9% (FY26)
ROE
6.41% (FY26)
Book value
₹70.6 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹571.90 / ₹401.00 (20 Nov 2026)
1-year return
11.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: AGARWALEYE

Incorporated in 2010, Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.